Gene · 79813
Papers2,587
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,587
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| G9a/GLP Targeting Ameliorates Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension. | Am J Respir Cell Mol Biol | 2023 | 36724371 | PubTator, text mining | PubMed |
| Cryo-EM structure of orphan G protein-coupled receptor GPR21. | MedComm (2020) | 2023 | 36721851 | PubTator, text mining | PubMed |
| Efficient generation of marmoset primordial germ cell-like cells using induced pluripotent stem cells. | Elife | 2023 | 36719274 | PubTator, text mining | PubMed |
| Recent advances in prostate cancer: WNT signaling, chromatin regulation, and transcriptional coregulators. | Asian J Androl | 2023 | 36695247 | PubTator, text mining | PubMed |
| Mitochondrial Energy Metabolism in the Regulation of Thermogenic Brown Fats and Human Metabolic Diseases. | Int J Mol Sci | 2023 | 36674862 | PubTator, text mining | PubMed |
| Proof-of-Concept Method to Study Uncharacterized Methyltransferases Using PRDM15. | Int J Mol Sci | 2023 | 36674842 | PubTator, text mining | PubMed |
| Development of tailored splice-switching oligonucleotides for progressive brain disorders in Europe: development, regulation, and implementation considerations. | RNA | 2023 | 36669889 | PubTator, text mining | PubMed |
| Small molecule modulators of chromatin remodeling: from neurodevelopment to neurodegeneration. | Cell Biosci | 2023 | 36647159 | PubTator, text mining | PubMed |
| Epigenetic and post-translational modifications in autophagy: biological functions and therapeutic targets. | Signal Transduct Target Ther | 2023 | 36646695 | PubTator, text mining | PubMed |
| A specific G9a inhibitor unveils BGLT3 lncRNA as a universal mediator of chemically induced fetal globin gene expression. | Nat Commun | 2023 | 36635268 | PubTator, text mining | PubMed |
| Tumor biomarkers and efficacy in patients treated with trastuzumab emtansine + pertuzumab versus standard of care in HER2-positive early breast cancer: an open-label, phase III study (KRISTINE). | Breast Cancer Res | 2023 | 36631725 | PubTator, text mining | PubMed |
| The role of the gut microbiota in patients with Kleefstra syndrome. | Am J Med Genet B Neuropsychiatr Genet | 2023 | 36630271 | PubTator, text mining | PubMed |
| Peripheral B cells from patients with hepatitis C virus-associated lymphoma exhibit clonal expansion and an anergic-like transcriptional profile. | iScience | 2023 | 36619973 | PubTator, text mining | PubMed |
| Psychosis and autism without functional regression in a patient with Kleefstra syndrome. | Psychiatr Genet | 2023 | 36617745 | PubTator, text mining | PubMed |
| ZFP462 safeguards neural lineage specification by targeting G9A/GLP-mediated heterochromatin to silence enhancers. | Nat Cell Biol | 2023 | 36604593 | PubTator, text mining | PubMed |
| HIV silencing and cell survival signatures in infected T cell reservoirs. | Nature | 2023 | 36599978 | PubTator, text mining | PubMed |
| Real-World Use of Once-Weekly Semaglutide in Type 2 Diabetes: Results from SemaglUtide Real-world Evidence (SURE) Germany. | Exp Clin Endocrinol Diabetes | 2023 | 36599459 | PubTator, text mining | PubMed |
| Role of primary aging hallmarks in Alzheimer´s disease. | Theranostics | 2023 | 36593969 | PubTator, text mining | PubMed |
| Non-synonymous, synonymous, and non-coding nucleotide variants contribute to recurrently altered biological processes during retinoblastoma progression. | Genes Chromosomes Cancer | 2023 | 36550020 | PubTator, text mining | PubMed |
| BRD8 maintains glioblastoma by epigenetic reprogramming of the p53 network. | Nature | 2023 | 36544023 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79813/papers?page=20